Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma

Annals of Allergy, Asthma and Immunology

Volumn 81, Issue 1, 1998, Pages 51-58

  Weinstein, Steven F ^a   Pearlman, David S ^b   Bronsky, Edwin A ^c   Byrne, Austin ^d   Arledge, Terri ^d   Liddle, Roger ^d   Stahl, Edmundo ^d  

^a Allerg Asthma Specialists Med Grp   (United States)

^b Respiratory Institute   (United States)

^c AAAA Medical Research Group   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SALBUTAMOL; SALMETEROL XINAFOATE;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHODILATATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; FLOWMETER; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031815609     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63109-2     Document Type: Article

References (33)

1. Kemp JP, Bierman CW, Cocchetto DM. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring. Ann Allergy 1993;70:316-22.
2. Bronsky EA, Kemp JP, Orgel HA, Bierman CW, et al. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. Chest 1994;105: 1032-7.
3. Derom EY, Pauwels RA, Van der Straeten ME. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. J Allergy Clin Immunol 1992; 89:811-5.
4. Maconochie J, Forster J, Fowler P, Thomas M. An initial comparison of salmeterol and salbutamol against histamine-induced bronchoconstriction in healthy subjects. Br J Clin Pharmacol 1988;25:115P.
5. Twentyman OP, Finnerty JP, Harris A, Palmer J, et al. Protection against allergen-induced asthma by salmeterol. Lancet 1990;336:1338-42.
6. Dhillon DP. Studies in exercise-induced asthma. Eur Respir Rev 1991; 1:265-7.
7. Anderson SD, Rodwell LT, Du Toit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991;100:1254-60.
8. Carter R, Anderson K, Watkin S, Boyd G. Duration of bronchodilating effect of inhaled salmeterol in asthma: dry powder compared with metered dose aerosol delivery systems. Am Rev Respir Dis 1991;143:A649.
9. Boyd G, Anderson K, Carter R. A 12 hour placebo controlled comparison of the bronchodilator performance of salmeterol and albuterol. Am Rev Respir Dis 1990;141:A206.
10. Boyd G, Anderson K, Carter R. Placebo controlled comparison of the bronchodilator performance of salmeterol and salbutamol over 12 hours. Thorax 1990;45:340P.
11. Lundback B, Rawlinson DW, Palmer JB. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. Thorax 1993;48: 148-53.
12. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992;327:1420-5.
13. D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, et al. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994;271:1412-6.
14. Lundbäck B, et al. A 3 months comparison of salmeterol and albuterol dry powder in mild to moderate asthmatic patients. Am Rev Respir Dis 1991; 143:A651.
15. Britton MG, Earnshaw JS, Palmer JB. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. Eur Respir J 1992;5:1062-7.
16. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344: 219-24.
17. Boner A. Salmeterol: long-term studies in children [Abstract]. Eur Respir J 1992;5(suppl 15):318S.
18. Gustafsson PM, von Berg A, Jenkins MM. Salmeterol 50 μg twice daily in the treatment of mild-to-moderate asthma in childhood - a comparison of two inhalation devices. Eur J Clin Res 1994;5:63-73.
19. Weinstein S, Chervinsky P, Pollard SJ, Bronsky EA, et al. A one-week dose-ranging study of inhaled salmeterol in children with asthma. J Asthma 1997; 34:43-52.
20. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136:225-44.
21. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: Saunders, 1971.
22. van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst 1958;37(part 3):351-61.
23. Meijer GG, Postma DS, Mulder PGH, Van Aalderen WMC. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids. Am J Respir Crit Care Med 1995;152:1887-92.
24. Simons FER, Soni NR, Watson WTA, Becker AB. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma. J Allergy Clin Immunol 1992;90:840-6.
25. Verberne AAPH, Hop WCJ, Bos AB, Kerrebijn KF. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. J Allergy Clin Immunol 1993;91: 127-34.
26. International consensus report on diagnosis and management of asthma. Bethesda, MD: National Asthma Education Program, Office of Prevention, Education, and Control, National Heart, Lung, and Blood Institute, National Institutes of Health, 1992.
27. Highlights of the expert panel report 2: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health (National Heart, Lung, and Blood Institute), 1997. NIH Publication, Number 97-4051A.
28. Guidelines for management of asthma in adults: I - Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Br Med J 1990; 301:651-3.
29. Guidelines for management of asthma in adults: II - Acute severe asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. Br Med J 1990;301:797-800.
30. Levison H. Canadian consensus on the treatment of asthma in children. Can Med Assoc J 1991;145:1449-55.
31. Pedersen S, Frost L, Amfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986;41:118-24.
32. Zora JA, Lutz CN, Tinkelman DG. Assessment of compliance in children using inhaled beta adrenergic agonists. Ann Allergy 1989;62:406-9.
33. Meades C, Churcher KM, Palmer JBD. An evaluation of the ease of handling the Diskhaler dry powder inhaler by asthmatic patients. Eur J Clin Res 1992;3:43-50.